The combination of sorafenib and radiation preferentially inhibits breast cancer stem cells by suppressing HIF-1α expression
Publisher: Spandidos Publications
ISSN: 1021-335X
Source: Oncology Reports, Vol.29, Iss.3, 2013-01, pp. : 917-924
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract